Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Prevalence Of Chronic Disease
3.1.2. Advancements In Technology
3.1.3. Rising Approval Of Novel Oral Anticoagulants (Noacs)
3.2. Key Restraints
3.2.1. Side Effects Associated With Anticoagulants Treatment
3.2.2. High Price Of Noacs
3.2.3. Stringent Government Regulations

4. Key Analytics
4.1. Porter’S Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Anticoagulants Market
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Application
5.1. Atrial Fibrillation & Heart Attack
5.2. Pulmonary Embolism (Pe)
5.3. Deep Vein Thrombosis (Dvt)
5.4. Stroke
5.5. Other Applications

6. Market By Route Of Administration
6.1. Oral Anticoagulants
6.2. Injectable Anticoagulants

7. Market By Drug Class
7.1. Noacs
7.1.1. Xarelto
7.1.2. Eliquis
7.1.3. Pradaxa
7.1.4. Savaysa & Lixiana
7.1.5. Bevyxxa
7.2. Heparins & Low-Molecular-Weight Heparins (Lmwhs)
7.3. Vitamin K Antagonists
7.4. Other Drug Class

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.2. Canada
8.2. Europe
8.2.1. Market Size & Estimates
8.2.2. Key Growth Enablers
8.2.3. Key Challenges
8.2.4. Key Players
8.2.5. Country Analysis
8.2.5.1. Germany
8.2.5.2. France
8.2.5.3. United Kingdom
8.2.5.4. Italy
8.2.5.5. Russia
8.2.5.6. Belgium
8.2.5.7. Poland
8.2.5.8. Rest Of Europe
8.3. Asia Pacific
8.3.1. Market Size & Estimates
8.3.2. Key Growth Enablers
8.3.3. Key Challenges
8.3.4. Key Players
8.3.5. Country Analysis
8.3.5.1. China
8.3.5.2. Japan
8.3.5.3. Australia & New Zealand
8.3.5.4. India
8.3.5.5. South Korea
8.3.5.6. Thailand
8.3.5.7. Indonesia
8.3.5.8. Vietnam
8.3.5.9. Rest Of Asia Pacific
8.4. Rest Of World
8.4.1. Market Size & Estimates
8.4.2. Key Growth Enablers
8.4.3. Key Challenge
8.4.4. Key Players
8.4.5. Regional Analysis
8.4.5.1. Latin America
8.4.5.2. Middle East & Africa

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Merger & Acquisitions
9.1.2. Product Launch & Developments
9.1.3. Partnership, Contract/ Agreement & Collaboration
9.1.4. Business Expansion/ Approval/ Announcement
9.2. Company Profile
9.2.1. Abbott Laboratories
9.2.2. Alexion Pharmaceutical Inc
9.2.3. Aspen Pharmacare Holdings Limited
9.2.4. Bayer Ag
9.2.5. Boehringer Ingelheim Gmbh
9.2.6. Bristol-Myers Squibb Company
9.2.7. Daiichi Sankyo
9.2.8. Dr. Reddy’S Laboratories
9.2.9. Glaxosmithkline Plc
9.2.10. Johnson & Johnson
9.2.11. Leo Pharma As
9.2.12. Merck & Co
9.2.13. Novartis Ag
9.2.14. Pfizer Inc
9.2.15. Sanofi



List of Figures


Figure 1: Chronic Conditions In Patients Hospitalized With Covid-19 In The United States
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: Global Anticoagulants Market, By Application, In 2020
Figure 7: Global Anticoagulants Market, By Atrial Fibrillation & Heart Attack, 2021-2028 (In $ Million)
Figure 8: Global Anticoagulants Market, By Pulmonary Embolism (Pe), 2021-2028 (In $ Million)
Figure 9: Global Anticoagulants Market, By Deep Vein Thrombosis (Dvt), 2021-2028 (In $ Million)
Figure 10: Global Anticoagulants Market, By Stroke, 2021-2028 (In $ Million)
Figure 11: Global Anticoagulants Market, By Other Applications, 2021-2028 (In $ Million)
Figure 12: Global Anticoagulants Market, By Route Of Administration, In 2020
Figure 13: Global Anticoagulants Market, By Oral Anticoagulants Market, 2021-2028 (In $ Million)
Figure 14: Global Anticoagulants Market, By Injectable Anticoagulants Market, 2021-2028 (In $ Million)
Figure 15: Global Anticoagulants Market, By Drug Class, In 2020
Figure 16: Global Anticoagulants Market, By Noacs, 2021-2028 (In $ Million)
Figure 17: Global Noacs Market, By Xarelto, 2018-2021 (In $ Million)
Figure 18: Global Noacs Market, By Eliquis, 2021-2021 (In $ Million)
Figure 19: Global Noacs Market, By Pradaxa, 2021-2021 (In $ Million)
Figure 20: Global Noacs Market, By Savaysa & Lixiana, 2021-2021 (In $ Million)
Figure 21: Global Noacs Market, By Bevyxxa, 2021-2021 (In $ Million)
Figure 22: Global Anticoagulants Market, By Heparins & Low-Molecular-Weight Heparins (Lmwhs), 2021-2028 (In $ Million)
Figure 23: Global Anticoagulants Market, By Vitamin K Antagonists, 2021-2028 (In $ Million)
Figure 24: Global Anticoagulants Market, By Other Drug Class, 2021-2028 (In $ Million)
Figure 25: North America Anticoagulants Market, Country Outlook, 2020 & 2028 (In %)
Figure 26: United States Anticoagulants Market, 2021-2028 (In $ Million)
Figure 27: Canada Anticoagulants Market, 2021-2028 (In $ Million)
Figure 28: Europe Anticoagulants Market, Country Outlook, 2020 & 2028 (In %)
Figure 29: Germany Anticoagulants Market, 2021-2028 (In $ Million)
Figure 30: France Anticoagulants Market, 2021-2028 (In $ Million)
Figure 31: United Kingdom Anticoagulants Market, 2021-2028 (In $ Million)
Figure 32: Italy Anticoagulants Market, 2021-2028 (In $ Million)
Figure 33: Russia Anticoagulants Market, 2021-2028 (In $ Million)
Figure 34: Belgium Anticoagulants Market, 2021-2028 (In $ Million)
Figure 35: Poland Anticoagulants Market, 2021-2028 (In $ Million)
Figure 36: Rest Of Europe Anticoagulants Market, 2021-2028 (In $ Million)
Figure 37: Asia Pacific Anticoagulants Market, Country Outlook, 2020 & 2028 (In %)
Figure 38: China Anticoagulants Market, 2021-2028 (In $ Million)
Figure 39: Japan Anticoagulants Market, 2021-2028 (In $ Million)
Figure 40: Australia & New Zealand Anticoagulants Market, 2021-2028 (In $ Million)
Figure 41: India Anticoagulants Market, 2021-2028 (In $ Million)
Figure 42: South Korea Anticoagulants Market, 2021-2028 (In $ Million)
Figure 43: Thailand Anticoagulants Market, 2021-2028 (In $ Million)
Figure 44: Indonesia Anticoagulants Market, 2021-2028 (In $ Million)
Figure 45: Vietnam Anticoagulants Market, 2021-2028 (In $ Million)
Figure 46: Rest Of Asia Pacific Anticoagulants Market, 2021-2028 (In $ Million)
Figure 47: Rest Of World Anticoagulants Market, Regional Outlook, 2020 & 2028 (In %)
Figure 48: Latin America Anticoagulants Market, 2021-2028 (In $ Million)
Figure 49: Middle East & Africa Anticoagulants Market, 2021-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - ANTICOAGULANTS
TABLE 2: GLOBAL ANTICOAGULANTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL ANTICOAGULANTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL ATRIAL FIBRILLATION & HEART ATTACK MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL ATRIAL FIBRILLATION & HEART ATTACK MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL PULMONARY EMBOLISM (PE) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL PULMONARY EMBOLISM (PE) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL STROKE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL STROKE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL ORAL ANTICOAGULANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL ORAL ANTICOAGULANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL INJECTABLE ANTICOAGULANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL INJECTABLE ANTICOAGULANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL ANTICOAGULANTS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: GLOBAL ANTICOAGULANTS MARKET, BY DRUG CLASS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL NOACS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL NOACS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL NOACS MARKET, BY TYPE, FORECAST YEARS, 2018-2021, (IN $ MILLION)
TABLE 25: GLOBAL HEPARINS & LMWH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL HEPARINS & LMWH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: GLOBAL VITAMIN K ANTAGONISTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: GLOBAL VITAMIN K ANTAGONISTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: GLOBAL OTHER DRUG CLASS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 30: GLOBAL OTHER DRUG CLASS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 31: GLOBAL ANTICOAGULANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 32: GLOBAL ANTICOAGULANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 33: NORTH AMERICA ANTICOAGULANTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: NORTH AMERICA ANTICOAGULANTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN NORTH AMERICA ANTICOAGULANTS MARKET
TABLE 36: EUROPE ANTICOAGULANTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: EUROPE ANTICOAGULANTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: LEADING PLAYERS OPERATING IN EUROPE ANTICOAGULANTS MARKET
TABLE 39: ASIA PACIFIC ANTICOAGULANTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 40: ASIA PACIFIC ANTICOAGULANTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 41: LEADING PLAYERS OPERATING IN ASIA PACIFIC ANTICOAGULANTS MARKET
TABLE 42: REST OF WORLD ANTICOAGULANTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 43: REST OF WORLD ANTICOAGULANTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 44: LEADING PLAYERS OPERATING IN REST OF WORLD ANTICOAGULANTS MARKET